Asian Journal of Cardiology Research

Myocarditis Caused by COVID-19: A Case Report and Literature Review

Mohammed Nachid *

Cardiology Division, Ibn Rochd University Hospital, Casablanca-20250, Morocco.

Karim Mounaouir

Cardiology Division, Ibn Rochd University Hospital, Casablanca-20250, Morocco.

Ali El Jazouli

Cardiology Division, Ibn Rochd University Hospital, Casablanca-20250, Morocco.

Meryem Haboub

Cardiology Division, Ibn Rochd University Hospital, Casablanca-20250, Morocco.

Bennouna Ghali

Cardiology Division, Ibn Rochd University Hospital, Casablanca-20250, Morocco.

Arous Salim

Cardiology Division, Ibn Rochd University Hospital, Casablanca-20250, Morocco.

Abdenasser Drighil

Cardiology Division, Ibn Rochd University Hospital, Casablanca-20250, Morocco.

Rachida Habbal

Cardiology Division, Ibn Rochd University Hospital, Casablanca-20250, Morocco.

*Author to whom correspondence should be addressed.

---

Abstract

Myocarditis, an inflammatory disease of the myocardium, has been identified as a potential complication of COVID-19. Here we present a case report of a 45-year-old male patient who was diagnosed with myocarditis following a COVID-19 infection. The patient presented with chest pain, dyspnea, and palpitations. ECG and cardiac MRI revealed findings consistent with myocarditis. The patient was treated with anti-inflammatory medication and recovered with no residual cardiac dysfunction. The case highlights the potential for COVID-19 to cause myocarditis and the importance of prompt diagnosis and management in these patients.

Keywords: Myocarditis, COVID-19, diagnosis, cardiac MRI, immunomodulatory agents, complications

---

---

---

References

Huang L, Zhao P, Tang D, et al. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc Imaging. 2020;13(11):2330-2339. DOI:10.1016/j.jcmg.2020.05.004

Tavazzi G, Pellegrini C, Maurelli M, et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail. 2020;22(5):911-915. DOI:10.1002/ejhf.1828

Hwang JK, Kang DH, Song JM, et al. 2019 Korean Society of Infectious Diseases guidelines for the diagnosis and treatment of cardiovascular diseases associated with COVID-19. Infect Chemother. 2020; 52(2):125-169.

DOI:10.3947/ic.2020.52.2.125

Bavishi C, Bonow RO, Trivedi V, Abbott JD, Messerli FH, Bhatt DL. Special Article - Acute myocardial injury in patients hospitalized with COVID-19 infection: A review. Prog Cardiovasc Dis. 2020;63(5): 682-689. DOI:10.1016/j.pcad.2020.03.007

Siripanthong B, Nazarian S, Muser D, et al. Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020;17(9): 1463-1471.

DOI:10.1016/j.hrthm.2020.05.001

Grün S, Schumm J, Greulich S, et al. Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. J Am Coll Cardiol. 2012;59(18):1604-1615. DOI:10.1016/j.jacc.2011.12.025

Ferreira VM, Schulz-Menger J, Holmvang G, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol. 2018;72(24): 3158- 3176. DOI:10.1016/j.jacc.2018.09.072

Lurz P, Eitel I, Adam J, et al. Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis. JACC Cardiovasc Imaging. 2012;5(5):513-524.

DOI:10.1016/j.jcmg.2012.01.017

Kociol RD, Cooper LT, Fang JC, et al. Recognition and initial management of fulminant myocarditis: A scientific statement from the American Heart Association. Circulation. 2020;141(6):e69-e92. DOI:10.1161/CIR.0000000000000745

Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol. 2009;53 (17):1475-1487. DOI:10.1016/j.jacc.2009.02.00

Diyya A, Thomas NV. Multiple micronutrient supplementation: As a supportive therapy in the treatment of COVID-19. BioMed Research International. 2022 Mar 14;2022.